We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Leading scientists at Dstl have made an exciting new discovery in the fight against some of the world’s deadliest diseases.
Enhanced stewardship approach for urinary tract infections (UTIs) resulted in a dramatic reduction in inappropriate prescribing.
Healthcare professionals prescribing nitrofurantoin should be alert to the risks of pulmonary and hepatic adverse drug reactions and advise patients to be vigilant for the signs and symptoms in need of further investigation.
A short course (3 to 7 days) may be used with caution in certain patients with an eGFR of 30 to 44 ml/min/1.73m2
The Innovative Licensing and Access Pathway (ILAP) aims to reduce the time to market for innovative medicines
It is estimated that at least 5,000 deaths are caused every year in England because antibiotics no longer work for some infections.
Disabling, long-lasting or potentially irreversible adverse reactions affecting musculoskeletal and nervous systems have been reported very rarely with fluoroquinolone antibiotics. Fluoroquinolone treatment should be discontinued at the first signs of a serious adverse reaction, including tendon pain or inflammation.
Upper Tribunal Administrative Appeals Chamber decision by Judge Brunner, QC on 16 October 2019.
Quinine should only be considered when cramps cause regular disruption of sleep.
PHE is issuing advice to people travelling to Egypt after a number of people, including children, have returned with a serious illness caused by E. coli infection.
Caution should be used in patients with known risk factors for venous thromboembolism in addition to the underlying disease. Patients older than 65 years of age are at an increased risk of serious infections and should be treated with tofacitinib...
New project investigates public health risks of ESBL E.Coli to develop intervention plans to reduce infections caused by these bacteria.
A new antibiotic resistance campaign is encouraging pet owners to accept vet advice that antibiotics might not always be the remedy.
Upper Tribunal Administrative Appeals Chamber decision by Judge Lane on 27 June 2016.
Employment Tribunal decision.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.